Yuqin Zhang
Papers
1
Total Citations
5
H-Index
1
About
Dr. Yuqin Zhang is a rising innovator in the field of plasmonic biosensing and cancer biomarker analysis, whose work bridges advanced nanomaterial engineering with high-sensitivity clinical diagnostics. Her most cited research introduces a groundbreaking monosaccharide-mediated strategy for the rational synthesis of a universal plasmonic platform, achieving broad-spectrum fluorescence enhancement. This platform enables the ultra-sensitive detection of oncological biomarkers in peripheral blood, a critical advancement for early cancer diagnosis and prognosis. By significantly boosting assay sensitivity, Dr. Zhang’s approach empowers clinicians to intervene while tumors remain localized, potentially improving patient outcomes before metastasis occurs. Her 2022 paper, garnering 5 citations, exemplifies her ability to design practical, high-performance tools for real-world medical challenges. Dr. Zhang’s contributions are particularly notable for their translational potential, offering a scalable and versatile method that could transform how cancer biomarkers are screened in routine clinical settings. As a researcher dedicated to merging materials chemistry with biomedical applications, her work stands as a promising step toward more effective, non-invasive cancer detection.
Research Focus
Key Achievements
Top Papers
- 1